Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma
Open Access
- 1 June 2008
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 21 (6), 691-699
- https://doi.org/10.1038/modpathol.2008.38
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations☆Human Pathology, 2006
- Abnormalities of the APC/β-catenin pathway in endometrial cancerOncogene, 2002
- The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1Oncogene, 2002
- CTNNB1 mutations and β-catenin expression in endometrial carcinomasHuman Pathology, 2002
- Molecular pathology of endometrial hyperplasia and carcinomaHuman Pathology, 2001
- K-ras mutations in endometrial carcinomas with microsatellite instabilityThe Journal of Pathology, 2000
- PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 casesHuman Pathology, 2000
- Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 casesHuman Pathology, 1998
- Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA contentCancer, 1994
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983